BFRGW

Keynote to explore the progress and remaining challenges of AI in drug discovery and developmentGAITHERSBURG, Md., Oct.

GAITHERSBURG, Md., Oct.

BullFrog AI has reached key milestones in its first commercial project with a top-five global pharmaceutical company, identifying and prioritising novel therapeutic targets for major depressive disorder using its AI platform.

Achieves key commercial project milestones utilizing its proprietary artificial intelligence (“AI”) and machine learning platform to identify and prioritize therapeutic targetsGAITHERSBURG, Md., Oct.

Here is how Bullfrog AI Holdings Inc. (BFRG) and Agilent Technologies (A) have performed compared to their sector so far this year.

GAITHERSBURG, Md., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.

Seasoned executives with track records of scaling growth and commercial initiatives across enterprise IT solutions, drug discovery and advanced therapy platforms formalize BullFrog AI’s commercial structure to accelerate growth initiativesGAITHERSBURG, Md.,…

Strengthened balance sheet provides capital runway into late 2027GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence (“AI”)…

BullFrog AI team will be available to discuss its end-to-end drug discovery and development workflow at booth 2957GAITHERSBURG, Md., April 14, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a…

BullFrog AI (BFRG) issued a letter to shareholders from founder and CEO Vin Singh stating the company has secured the financial runway to execute its strategy into late 2027 and is in active discussions with pharmaceutical and biotechnology organizations.

First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027GAITHERSBURG, Md., April 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW)…

Commercial agreement serves as high-profile third party validation of BullFrog AI’s proprietary capabilities Agreement utilizes BullFrog AI’s end-to-end analytical AI platform to accelerate drug discovery and development program GAITHERSBURG, Md., March 30,…